Celera, Genentech Sign Cancer Drug  Deal Celera Genomics Group of Rockville announced an agreement Tuesday to provide potential targets for cancer drugs to biotech giant Genentech Inc.\&lt;BR&gt;&lt;FONT face="verdana,MS Sans Serif,arial,helvetica" size="-2"\ color="#666666"&gt;&lt;B&gt;-The Washington Post&lt;/B&gt;&lt;/FONT&gt;